|
|
|
|
| LEADER |
02707nam a22003975i 4500 |
| 001 |
000287138 |
| 005 |
20211119082544.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100715s2009 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9781441901347
|
| 024 |
7 |
|
|a 10.1007/978-1-4419-0134-7
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Imaging in CNS Drug Discovery and Development :
|b Implications for Disease and Therapy /
|c edited by David Borsook, Lino R. Beccera, Edward Bullmore, Richard J. Hargreaves.
|
| 250 |
|
|
|a 1st ed. 2009.
|
| 260 |
# |
# |
|a New York, NY :
|b Springer New York :
|b Imprint: Springer,
|c 2009.
|
| 300 |
|
|
|a XVIII, 396 p. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a Background -- The Challenges and Opportunities -- Imaging of CNS Systems: Importance for Drug Development -- Imaging Approaches -- Anatomical Imaging: Volumetric Analysis -- Diffusion Tensor Imaging and Drug Development -- Functional Magnetic Resonance Imaging in Drug Development -- Magnetic Resonance Imaging of Pharmacological Systems -- Molecular Imaging: Basic Approaches -- Chemical Imaging: Magnetic Resonance Spectroscopy: The Basics -- Imaging CNS Drug Action -- Animal Imaging -- Incorporating Functional MRI into Clinical Pharmacology Trials -- Imaging Placebo Responses in the Brain -- Structural Imaging of Drug Actions in Neurodegenerative Diseases -- Molecular Imaging of the CNS: Drug Actions -- Imaging CNS Disease States -- Translational MRI in CNS Drug Discovery -- In Vivo Mouse Imaging and Spectroscopy in Drug Discovery -- Neuroimaging in Understanding Chronic Pain Mechanisms and the Development of New Therapies -- Neuroimaging Human Drug Addiction -- Anxiety: Uncover Roles of Stress Related Genes by Imaging Genetics -- Imaging CNS Disease States: Alzheimer’s Disease -- Brain Development and CNS Plasticity -- Imaging in CNS Disease States: PTSD -- Integrative Processes -- Integrative Processes: Neuroscience Clinical Imaging Biomarkers -- Reasons to Believe: The Potential of Imaging in CNS Drug Development.
|
| 650 |
|
0 |
|a Pharmacology.
|
| 650 |
|
0 |
|a Radiology.
|
| 650 |
|
0 |
|a Biotechnology.
|
| 650 |
|
0 |
|a Neurosciences.
|
| 650 |
|
0 |
|a Cancer research.
|
| 650 |
1 |
4 |
|a Pharmacology/Toxicology.
|
| 650 |
2 |
4 |
|a Imaging / Radiology.
|
| 650 |
2 |
4 |
|a Biotechnology.
|
| 650 |
2 |
4 |
|a Neurosciences.
|
| 650 |
2 |
4 |
|a Cancer Research.
|
| 700 |
1 |
|
|a Borsook, David.
|e editor.
|
| 700 |
1 |
|
|a Beccera, Lino R.
|e editor.
|
| 700 |
1 |
|
|a Bullmore, Edward.
|e editor.
|
| 700 |
1 |
|
|a Hargreaves, Richard J.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|